Sunflower Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 18.6% in First Three Quarters of 2022

Sunflower Pharmaceutical Group Co.,Ltd. (葵花药业集团股份有限公司) (002737.SZ) reported a net profit of 536.8 million yuan in the first three quarters of 2022, up 18.6% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, up 7.1% year-on-year.

At the end of the reporting period, it had 6.1 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 33.5%.